杏輝藥品工業股份有限公司
杏輝藥品工業股份有限公司為綜合型生技醫藥集團，產品涵蓋處方藥、科學中藥、醫美護膚品及功能性保健食品。公司亦跨足癌症輔助藥物研發，並提供專業醫藥 CDMO 委託製造服務。公司成立於 1977 年，總部位於台灣宜蘭。
該股 RSI(6) 為 52.8，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、60日、120日均線，跌破20日均線。KD 指標中性（K=59.3）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +53 | 0 | 0 | +53 |
| 08-07 | +29 | 0 | 0 | +29 |
| 08-06 | -65 | 0 | -1 | -66 |
| 08-05 | -178 | 0 | -1 | -179 |
| 08-04 | -95 | 0 | -6 | -101 |
| 08-03 | -111 | 0 | -39 | -150 |
| 07-31 | -248 | 0 | +2 | -246 |
| 07-30 | +92 | 0 | -40 | +52 |
| 07-29 | +51 | 0 | +1 | +52 |
| 07-28 | -59 | 0 | +58 | -1 |
| 07-27 | +5 | 0 | +2 | +7 |
| 07-24 | -64 | 0 | 0 | -64 |
| 07-23 | -522 | 0 | 0 | -522 |
| 07-22 | +135 | 0 | -16 | +119 |
| 07-21 | +101 | 0 | -1 | +100 |
| 07-20 | +154 | 0 | +3 | +157 |
| 07-17 | +22 | 0 | +1 | +23 |
| 07-16 | +234 | 0 | +1 | +235 |
| 07-15 | +44 | 0 | +5 | +49 |
| 07-14 | +91 | 0 | +2 | +93 |
| 07-13 | +49 | 0 | -1 | +48 |
| 07-09 | -22 | 0 | +1 | -21 |
| 07-08 | +20 | 0 | -4 | +16 |
| 07-07 | +425 | 0 | +10 | +435 |
| 07-06 | +363 | 0 | -1 | +362 |
| 07-03 | +170 | 0 | +2 | +172 |
| 07-02 | +47 | 0 | 0 | +47 |
| 07-01 | +121 | 0 | 0 | +121 |
| 06-30 | -50 | 0 | 0 | -50 |
| 06-29 | +222 | 0 | 0 | +222 |
| 06-26 | +31 | 0 | 0 | +31 |
| 06-25 | +55 | 0 | 0 | +55 |
| 06-24 | +227 | 0 | -1 | +226 |
| 06-22 | +77 | 0 | 0 | +77 |
| 06-18 | +114 | 0 | -3 | +111 |
| 06-17 | -7 | 0 | +3 | -4 |
| 06-16 | +48 | 0 | -3 | +45 |
| 06-15 | -113 | 0 | +4 | -109 |
| 06-12 | +157 | 0 | 0 | +157 |
| 06-10 | +74 | 0 | -2 | +72 |
| 06-09 | +138 | 0 | -1 | +137 |
| 06-08 | +83 | 0 | 0 | +83 |
| 06-04 | +65 | 0 | 0 | +65 |
| 06-03 | -70 | 0 | 0 | -70 |
| 06-02 | -105 | 0 | 0 | -105 |
| 06-01 | +112 | 0 | -11 | +101 |
| 05-29 | -86 | 0 | 0 | -86 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 2.79 億 | -7.4% | +3.8% |
| 2026/05 | 3.01 億 | +3.2% | +10.3% |
| 2026/04 | 2.91 億 | -8.1% | +7.6% |
| 2026/03 | 3.17 億 | +61.6% | +5.1% |
| 2026/02 | 1.96 億 | -37.2% | -17.4% |
| 2026/01 | 3.13 億 | -3.0% | +17.4% |
| 2025/12 | 3.22 億 | +14.6% | +10.7% |
| 2025/11 | 2.81 億 | +2.9% | +3.2% |
| 2025/10 | 2.74 億 | -16.7% | -5.5% |
| 2025/09 | 3.29 億 | +28.4% | +56.7% |
| 2025/08 | 2.56 億 | -12.3% | -8.8% |
| 2025/07 | 2.92 億 | - | +11.7% |